Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer

Clinical trial NCT05776524 · RECRUITING

Trial details

NCT number: NCT05776524
Sponsor: THERABIONIC INC.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer Metastatic Adenocarcinoma

Start date: 2023-06-13
Primary completion: 2027-07-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.